TY - JOUR
T1 - Outcomes and Risk Factors for Graft Loss
T2 - Lessons Learned from 1,056 Pediatric Kidney Transplants at the University of Minnesota
AU - Chinnakotla, Srinath
AU - Verghese, Priya
AU - Chavers, Blanche
AU - Rheault, Michelle N.
AU - Kirchner, Varvara
AU - Dunn, Ty
AU - Kashtan, Clifford
AU - Nevins, Thomas
AU - Mauer, Michael
AU - Pruett, Timothy
AU - Kim, Youngki
AU - Najera, Lydia
AU - Hanna, Christian
AU - Kizilbash, Sarah
AU - Cook, Marie
AU - Cisek, Lars J.
AU - Gillingham, Kristen
AU - Yang, Yi
AU - Matas, Arthur
AU - Najarian, John
N1 - Publisher Copyright:
© 2017 American College of Surgeons
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Background Advances in immunosuppression, surgical techniques, and management of infections in children receiving kidney transplants have affected outcomes. Study Design We analyzed a prospectively maintained database of pediatric kidney transplantations. Results From June 1963 through October 2016, we performed 1,056 pediatric kidney transplantations. Of these, 129 were in children less than 2 years old. The most common indications for transplant were congenital anomalies (dysplastic kidneys), obstructive uropathy, and congenital nephrotic syndrome. Living donors constituted 721 (68%) of all donors. The graft and patient survival rates remarkably improved for both deceased and living donor recipients (p = 0.001). Currently, graft survival rates for deceased donor recipients are 92% at 1 year, 76% at 5 years, and 57% at 10 years post-transplant; for living donor recipients, 96% at 1 year, 85% at 5 years, and 78% at 10 years. The graft half-life was 19 years in deceased donor recipients, compared with 25 years in living donor recipients (p ≤ 0.001). Acute rejection was the most common cause of graft loss in the first year post-transplant. The following risk factors were associated with an increased risk of graft loss: deceased donor grafts (p = 0.0001), retransplant (p = 0.02), ages 11 to 18 years (p = 0.001) and pre-transplant urologic issues (p = 0.04). Living donor grafts (p ≤ 0.0001) and pre-emptive transplants (p = 0.02) were associated with decreased risks of graft loss. Conclusions The success rates of pediatric kidney transplants have significantly improved. Pre-emptive kidney transplantation with a living donor graft continues to be superior and should be the choice in children with end-stage renal disease.
AB - Background Advances in immunosuppression, surgical techniques, and management of infections in children receiving kidney transplants have affected outcomes. Study Design We analyzed a prospectively maintained database of pediatric kidney transplantations. Results From June 1963 through October 2016, we performed 1,056 pediatric kidney transplantations. Of these, 129 were in children less than 2 years old. The most common indications for transplant were congenital anomalies (dysplastic kidneys), obstructive uropathy, and congenital nephrotic syndrome. Living donors constituted 721 (68%) of all donors. The graft and patient survival rates remarkably improved for both deceased and living donor recipients (p = 0.001). Currently, graft survival rates for deceased donor recipients are 92% at 1 year, 76% at 5 years, and 57% at 10 years post-transplant; for living donor recipients, 96% at 1 year, 85% at 5 years, and 78% at 10 years. The graft half-life was 19 years in deceased donor recipients, compared with 25 years in living donor recipients (p ≤ 0.001). Acute rejection was the most common cause of graft loss in the first year post-transplant. The following risk factors were associated with an increased risk of graft loss: deceased donor grafts (p = 0.0001), retransplant (p = 0.02), ages 11 to 18 years (p = 0.001) and pre-transplant urologic issues (p = 0.04). Living donor grafts (p ≤ 0.0001) and pre-emptive transplants (p = 0.02) were associated with decreased risks of graft loss. Conclusions The success rates of pediatric kidney transplants have significantly improved. Pre-emptive kidney transplantation with a living donor graft continues to be superior and should be the choice in children with end-stage renal disease.
UR - http://www.scopus.com/inward/record.url?scp=85013883548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013883548&partnerID=8YFLogxK
U2 - 10.1016/j.jamcollsurg.2016.12.027
DO - 10.1016/j.jamcollsurg.2016.12.027
M3 - Article
C2 - 28254584
AN - SCOPUS:85013883548
SN - 1072-7515
VL - 224
SP - 473
EP - 486
JO - Journal of the American College of Surgeons
JF - Journal of the American College of Surgeons
IS - 4
ER -